Carmen Scheibenbogen

Author

Charité - Universitätsmedizin Berlin ORCID

Also Known As

C Scheibenbogen, C. SCHEIBENBOGEN, C. Scheibenbogen, Carmen M. Scheibenbogen, Carmen Scheibenbogen, Christina Pley, Scheibenbogen, Carmen, Thomas Harrer, Yaryna Romanyshyn

403

Publications

15K

Citations

H-Index

158

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Freie Universität Berlin Humboldt-Universität zu Berlin Berlin-Brandenburger Centrum für Regenerative Therapien Heidelberg University

About

Carmen Scheibenbogen is an author at Charité - Universitätsmedizin Berlin specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	79	5.1K
2	Health Sciences	6	6	473
3	Public Health	3	3	371
4	Engineering	1	1	32
5	Social Sciences	1	1	20

Carmen Scheibenbogen

179

Publications

11.8K

Citations

H-Index

Page 1

	Year	Citations
Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis H.-G. Leser, Carmen Scheibenbogen, A. Heinisch, Gastroenterology InflammationCytokineImmunologyChronic InflammationInflammatory Marker	1991	354
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses Giulia Nizzoli, Jana Krietsch, Anja Weick, Blood	2013	313
Quantitative DNA Methylation Analysis of <i>FOXP3</i> as a New Method for Counting Regulatory T Cells in Peripheral Blood and Solid Tissue Georg Wieczorek, Anne Marie Asemissen, Fabian Model, Cancer Research	2009	311
A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity Claudia Kedor, Helma Freitag, Lil Meyer‐Arndt, Nature Communications	2022	305
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS Ulrich Keilholz, Anne Letsch, Antonia Busse, Blood	2009	299
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) Milan Haffke, Helma Freitag, Gordon Rudolf, Journal of Translational Medicine	2022	263
CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia Carmen Scheibenbogen, Anne Letsch, Eckhard Thiel, Blood	2002	250
Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome Madlen Loebel, Patricia Grabowski, Harald Heidecke, Brain Behavior and Immunity Immune RegulationImmunologyImmune SystemImmune DysregulationRituximab Maintenance Treatment	2015	240
Surface Phenotype Analysis of Human Monocyte to Macrophage Maturation Reinhard Andreesen, Wolfram Brugger, Carmen Scheibenbogen, Journal of Leukocyte Biology	1990	210
Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. Ulrich Keilholz, S.H. Goey, Cornelis J.A. Punt, Journal of Clinical Oncology	1997	196

Page 1